Robert Orlowski

Robert Orlowski on patients with newly diagnosed multiple myeloma to benefit from Isa-VRd as initiation therapy

MD Anderson Cancer Center shared on X:

Patients with newly diagnosed multiple myeloma may benefit from Isa-VRd as initiation therapy, our Dr. Robert Orlowski reported at ASH24 to an audience spilling over into three overflow rooms.

Robert Orlowski on patients with newly diagnosed multiple myeloma to benefit from Isa-VRd as initiation therapy